Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease. - Mostafa A. Hussien; Ahmed E. M. Abdelaziz (Netw. Model. Anal. Health Informatics Bioinform., 2020)